Who We Are

BCAN - the Bladder Cancer Advocacy Network - is the first national advocacy organization dedicated to increasing public awareness about bladder cancer; to advancing bladder cancer research; and to providing educational and support services for the bladder cancer community. Founded in May 2005, BCAN is a cooperative effort among bladder cancer survivors, their families and caregivers, and the medical community.

Running to Raise Awareness of Bladder Cancer

In December, BCAN supporter Randy Van Dusen ran the California International Marathon to raise awareness of bladder cancer.  Now, Randy is preparing for the American River 50 Mile Endurance Run.  Click here to read Randy’s story.

BCAN Patient Forum Saturday, November 7 in San Francisco

The slides from the doctors’ presentations at our recent forum in San Francisco are available here.  Webcasts of these presentations will be available in January.

Researchers recruiting men and women diagnosed with bladder cancer within the last four years for a telephone survey

Click here for more information.

New Drug Available for Bladder Cancer

Valstar, an intravesical therapy drug for bladder cancer, is now available.  It is FDA-approved for patients with BCG-refractory carcinoma in situ (CIS) for whom immediate removal of the bladder would be associated with unacceptable medical risks.  Click here for more information.

Is There a Popularity Contest in Cancer Funding?

Bladder cancer is the fifth most common cancer  yet it ranks 19th in funding.
ABC News asks why some cancers get more money per patient than others. Click here to read the entire story.